A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This study is looking at a particular treatment for multiple myeloma, which is a type of cancer. The study is using two drugs called Trametinib and Dabrafenib to see if they can help treat the cancer.
This study is looking at a particular treatment for multiple myeloma, which is a type of cancer. The study is using two drugs called Trametinib and Dabrafenib to see if they can help treat the cancer.
*Third Opinion AI Generated Synopsis
Trial Summary
This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: Trametinib Dabrafenib
This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: Trametinib Dabrafenib
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: